Taro-gliclazide Mr: May Contain The Presence Of Pink Coloured Stain (identified As Candesartan Cilexetil)
Taro-Gliclazide MR tablets are being recalled across Canada because some packages contain a pink stain identified as Candesartan Cilexetil, a different medication, on the tablets. This is a Class I recall, meaning there is a serious potential health risk. The recall affects Taro-Gliclazide MR products distributed throughout Canada.
- Product
- TARO-GLICLAZIDE MR
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-05-22
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/262d6fca-5212-4c36-84c2-8a456bd7f11e